Noul Co.,Ltd. (KOSDAQ:376930)

South Korea · Delayed Price · Currency is KRW

1,594.00

-62.00 (-3.74%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Manufacture and Sale of Blood Test Devices	1.60B	2.73B	541.88M	1.48B	295.26M
Manufacture and Sale of Blood Test Devices Growth	-41.42%	404.51%	-63.27%	399.66%	-
Total	1.60B	2.73B	541.88M	1.48B	295.26M
Total Growth	-41.42%	404.51%	-63.27%	399.66%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
North and Central America	-	-	72.22M	-	-
Africa	363.33M	815.52M	505.33M	-	-
Africa Growth	-55.45%	61.39%	-	-	-
Europe	74.67M	6.98M	80.09M	-	-
Europe Growth	969.22%	-91.28%	-	-	-
South Korea	1.15B	1.85B	-157.53M	1.48B	295.26M
South Korea Growth	-37.75%	-	-	399.66%	-
Asia	-	60.40M	41.78M	-	-
Asia Growth	-	44.58%	-	-	-
Middle East	11.34M	-	-	-	-
Total	1.60B	2.73B	541.88M	1.48B	295.26M
Total Growth	-41.42%	404.51%	-63.27%	399.66%	-

Source: S&P Global Market Intelligence.